Who Are The "Top Managers"?
Two pharmaceutical executives, Sir Richard Sykes of Glaxo Wellcome andRay Gilmartin of Merck & Co, are featured in a list of 25 "Top Managers in 1996" compiled by Business Week magazine of the USA.
Mr Gilmartin featured as a result of his efforts to boost morale, instill a spirit of team work and make pharmaceutical research a key focus at Merck & Co, said the magazine. In 1996, expected net income for the firm is $3.9 billion.
Sir Richard was chosen for his "bold strokes" in acquiring Wellcome at a time when Glaxo's future was shadowed by its blockbuster antiulcerant Zantac (ranitidine) facing patent expiry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze